Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.69 USD
Change Today +0.0211 / 3.16%
Volume 1.1M
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

cytori therapeutics inc (CYTX) Snapshot

Open
$0.68
Previous Close
$0.67
Day High
$0.70
Day Low
$0.66
52 Week High
06/12/14 - $2.54
52 Week Low
11/12/14 - $0.36
Market Cap
96.0M
Average Volume 10 Days
1.7M
EPS TTM
$-0.56
Shares Outstanding
139.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CYTORI THERAPEUTICS INC (CYTX)

cytori therapeutics inc (CYTX) Related Bloomberg News

View More Bloomberg News

cytori therapeutics inc (CYTX) Related Businessweek News

View More BusinessWeek News

cytori therapeutics inc (CYTX) Details

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices and consumable sets, and other ancillary products for the customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan, and other regions. The company markets its products to hospitals, clinics, tissue banks, and stem cell banking companies through direct sales representatives, distributors, and partners worldwide. Cytori Therapeutics, Inc. was founded in 1996 and is headquartered in San Diego, California.

78 Employees
Last Reported Date: 03/16/15
Founded in 1996

cytori therapeutics inc (CYTX) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $437.4K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $79.1K
President of Asia Pacific
Total Annual Compensation: $367.0K
Chief Medical Officer and Executive Vice Pres...
Total Annual Compensation: $400.0K
Compensation as of Fiscal Year 2014.

cytori therapeutics inc (CYTX) Key Developments

Cytori Therapeutics, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended March 31, 2015; Provides Financial Guidance for the Year 2015

Cytori Therapeutics, Inc. announced unaudited consolidated earnings results for first quarter ended March 31, 2015. For the quarter, the company reported product revenues of $902,000, operating loss of $20,997,000, net loss allocable to common stock holders of $22,619,000 or $0.21 per basic and diluted share, net cash used in operating activities of $5,030,000, purchases of property and equipment of $187,000 compared to the product revenues of $1,031,000, operating loss of $9,547,000, net loss allocable to common stock holders of $10,400,000 or $0.14 per basic and diluted share, net cash used in operating activities of $8,962,000, purchases of property and equipment of $287,000 for the same quarter a year ago. The company expected quarterly operating burn will increase over the following quarters. The company guidance is unchanged, and company continue to expect operating cash burn of approximately $25 million in 2015. The company expected contract revenues to increase throughout 2015, and the company reaffirm contract revenue guidance of $6 million to $8 million for 2015.

Cytori Therapeutics, Inc. to Report Q1, 2015 Results on May 11, 2015

Cytori Therapeutics, Inc. announced that they will report Q1, 2015 results at 5:30 PM, US Eastern Standard Time on May 11, 2015

Cytori Therapeutics, Inc., Q1 2015 Earnings Call, May 11, 2015

Cytori Therapeutics, Inc., Q1 2015 Earnings Call, May 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTX:US $0.69 USD +0.0211

CYTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Athersys Inc $1.35 USD -0.01
Cardica Inc $0.42 USD -0.006
NeoStem Inc $2.63 USD -0.03
Nuo Therapeutics Inc $0.24 USD -0.015
StemCells Inc $0.65 USD -0.0272
View Industry Companies
 

Industry Analysis

CYTX

Industry Average

Valuation CYTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTORI THERAPEUTICS INC, please visit www.cytori.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.